Langlenatide
Langlenatide Uses, Dosage, Side Effects, Food Interaction and all others data.
Langlenatide is under investigation in clinical trial NCT03713684 (Efficacy and Safety of Langlenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Alone or in Combination With Oral Antidiabetic Drug(s)).
| Trade Name | Langlenatide |
| Generic | Efpeglenatide |
| Efpeglenatide Other Names | Efpeglenatide, Langlenatide |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Langlenatide
